微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -2.75% | -139.13% | 89.3% | 66/70 | 2.21% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | -25.69% | -3852.31% | -540.65% | 65/70 | 3.08% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | -4.01% | -535.87% | -16.91% | 62/70 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | -3.43% | -772.55% | -198.26% | 63/70 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | -1.15% | -222.34% | -76.92% | 63/70 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | -0.65% | -138.69% | -170.65% | 58/70 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 0.92% | -59.65% | 80.39% | 59/70 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 0.51% | -30.14% | -45.74% | 60/70 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 0.94% | -48.35% | -44.05% | 56/70 | 3.14% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 1.68% | -50.15% | -26.32% | 53/70 | 6.41% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 2.28% | -61.22% | 212.33% | 55/70 | 5.07% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 0.73% | -79.49% | -59.89% | 59/70 | 3.13% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 1.82% | -41.67% | -45.99% | 40/70 | 2.15% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 3.37% | 15.02% | -42.69% | 51/70 | 4.45% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 5.88% | 92.16% | 65.17% | 43/70 | 7.44% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 3.56% | 77.11% | 14.1% | 42/70 | 4.61% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 3.12% | 119.72% | 6.48% | 20/70 | 2.67% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 2.93% | -21.02% | -4.25% | 52/70 | 0.09% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 3.06% | 3.73% | 52.24% | 53/70 | 6.69% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 2.01% | -16.25% | 41.55% | 48/70 | 3.67% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 1.42% | -22.83% | -61.73% | 46/70 | 2.09% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 3.71% | 143.8% | 25.76% | 48/70 | 5.69% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 2.95% | 252.06% | 22.92% | 49/70 | 7.19% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 2.4% | 1400% | 30.43% | 49/70 | 4.65% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 1.84% | 97.85% | 121.72% | 46/70 | 2.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | -8.47% | -380.46% | -336.6% | 64/70 | 7.76% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | -1.94% | -152.15% | -1312.5% | 63/70 | 7.93% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 0.16% | -95.63% | -82.8% | 61/70 | 4.95% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 0.93% | -76.87% | -69.21% | 54/70 | 2.72% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 3.02% | -45.09% | -18.82% | 58/70 | 9.83% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 3.72% | -36.08% | 1.64% | 56/70 | 8.33% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 3.66% | -32.97% | -8.96% | 46/70 | 5.2% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 4.02% | -36.69% | -26.91% | 14/70 | 2.61% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 5.5% | -40.86% | -5.5% | 53/70 | 10% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 5.82% | -63.09% | 6.59% | 39/70 | 9.36% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 5.46% | -0.73% | -14.02% | 30/70 | 5.05% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 6.35% | 17.38% | -31.72% | 5/70 | 4.07% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 9.3% | 123% | -41.03% | 42/70 | 11.33% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 15.77% | 3054% | 186.73% | 7/70 | 8.45% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 5.5% | 4028.57% | 1.66% | 32/70 | 5.5% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 5.41% | 391.82% | 113.38% | 5/70 | 2.94% | 济川药业 | 21.37% | 行业排名> |